Neuromodulation for Concussion
(CI-tDCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a brain stimulation method called transcranial direct current stimulation (tDCS) to aid children in recovering from mild traumatic brain injuries (mTBI), such as concussions. The researchers aim to determine if tDCS can improve communication between brain areas to alleviate motor and cognitive issues. Children who have experienced a concussion in the past year and face symptoms like difficulty with planning or movement may be suitable candidates. Healthy children without a concussion history will also participate for comparison. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance recovery methods for children with mTBI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What prior data suggests that this brain stimulation method is safe for children with mild traumatic brain injury?
Research shows that transcranial direct current stimulation (tDCS) is generally safe for people. Studies have found no serious side effects, such as brain injury, linked to tDCS use. This brain stimulation method is also considered safe and well-tolerated in children, which is crucial for this trial focusing on young people with mild traumatic brain injury.
In past studies, researchers used tDCS alongside other therapies and found it safe and practical. While research continues, early results are promising for its use in improving thinking skills. Overall, tDCS is viewed as a low-risk treatment option.12345Why are researchers excited about this trial?
Unlike the standard care for mild traumatic brain injury, which often involves rest and symptom management, transcranial direct current stimulation (tDCS) offers a unique approach by directly modulating brain activity. tDCS uses a low electrical current, delivered through electrodes placed on the scalp, to target specific brain regions affected by concussion. Researchers are excited about tDCS because it has the potential to improve recovery by enhancing neural plasticity and cognitive function, providing a non-invasive and potentially faster-acting alternative to conventional treatments.
What evidence suggests that transcranial direct current stimulation (tDCS) might be an effective treatment for mild traumatic brain injury (mTBI)?
This trial will evaluate the effects of transcranial direct current stimulation (tDCS) in youth with mild traumatic brain injury (mTBI). Research has shown that tDCS can improve movement and thinking skills, with studies finding it aids recovery after a stroke by enhancing these abilities. Evidence also suggests that tDCS can enhance thinking skills in various conditions. Although researchers have studied tDCS less in mTBI, its potential to help the brain change and adapt suggests it might repair brain areas affected by mTBI. In summary, early findings are promising for tDCS as a way to aid recovery in mTBI, but more research is needed to confirm its benefits for this condition.16789
Who Is on the Research Team?
Ghazala Saleem, EdD
Principal Investigator
State University of New York at Buffalo
Are You a Good Fit for This Trial?
This trial is for children aged 10-15 who have had a mild traumatic brain injury (mTBI) or concussion in the past year and are experiencing ongoing symptoms like trouble with motor skills. They must be at least 6 weeks post-injury, speak English fluently, and have no prior history of concussions.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Initial behavioral and neuroimaging testing conducted
Treatment
Ten sessions of 1.5 mA real tDCS and 10 sessions of sham tDCS administered with a 2-week washout period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- tDCS
Trial Overview
The study is exploring the use of tDCS (transcranial direct current stimulation), a non-invasive brain stimulation technique, to improve motor and cognitive functions in youths with mTBI. It also aims to assess new ways to measure brain communication changes during recovery.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Behavioral as well as neuroimaging measurements will be administered at the final post-anodal transcranial direct current stimulation (tDCS), final post-sham tDCS, and at 30-day follow-up visits. tDCS will be administered after the initial behavioral and neuroimaging testing. Ten sessions of 1.5 mA real tDCS and 10 sessions of sham tDCS will be administered using Neurocom (Germany) DC stimulator and two 5x7 electrodes, moistened in saline solution, to 10 participants with mTBI following a cross-over design with a 2-week washout period. The location of the brain regions will be determined using either the Transcranial Magnetic Stimulation Neuronavigation or Brainsight Neuronavigation system. The anode will be placed over pre-determined brain regions, whereas the cathode will be placed either over Fp2 (contralateral supraorbital) or other suitable reference areas.
Never-concussed age-and gender-matched healthy controls will not receive any intervention. Behavioral and neuroimaging measurements will be administered only once, at the initial visit.
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Published Research Related to This Trial
Citations
Transcranial Direct Current Stimulation as a Treatment Tool ...
Based on the review, there is limited evidence of tDCS improving cognitive and motor performance. Surprisingly, there were only three studies that used tDCS in ...
2.
frontiersin.org
frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2025.1552387/fullTranscranial direct current stimulation in individuals with ...
Research has demonstrated positive results from the application of tDCS after stroke, such as improved motor and cognitive function, when tDCS ...
Transcranial direct current stimulation (tDCS) effects on ...
Multiple studies showed improved coma recovery scales in disorders of consciousness, and improved cognition on neuropsychological assessments.
"Cognitive Rehabilitation With Direct Current Transcranial ...
Transcranial Direct Current Stimulation (tDCS) has shown effectiveness in enhancing neuroplasticity in various neurological and psychiatric conditions 63.
Effectiveness of rTMS and tDCS treatment for chronic TBI ...
This study aims at providing a systematic review and meta-analysis on the effectiveness of repetitive transcranial magnetic stimulation (TMS) and transcranial ...
Safety of transcranial Direct Current Stimulation: Evidence ...
In this review, tDCS safety indicates the absence of a Serious Adverse Effect including brain tissue injury related to tDCS application. It is necessary to ...
7.
headachejournal.onlinelibrary.wiley.com
headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14887The safety and feasibility of transcranial direct current ...
Conclusion. The combination of transcranial direct stimulation and exercise therapy is safe and feasible for treating cervicogenic headache.
A map of evidence using transcranial direct current ...
Limited but promising evidence supports tDCS as safe and effective for cognition across all levels of TBI acuity and severity (Begemann et al., ...
Safety and tolerability of transcranial magnetic and direct ...
Standard non-invasive brain stimulation paradigms are safe and well-tolerated in children and should be considered minimal risk.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.